Development of a soluble epoxide hydrolase inhibitor to spare or replace opioid analgesics

Ended Cooperative Agreement Awarded Last action

Award ID
UG3DA048767
Recipient
Awarding agency
Obligated
$6,082,654

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Originally
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Place of performance
Davis, CA, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Amendment $2,419,751
Amendment -$2,419,751
Amendment $3,046,519
Amendment $0
Amendment $0
Original award $3,036,135
Show all 19

Quick answers

Who received award UG3DA048767?

UG3DA048767 was awarded to Eicosis LLC by National Institute on Drug Abuse (National Institutes of Health) on September 30, 2019.

How much is award UG3DA048767 worth?

$6,082,654 has been obligated on UG3DA048767.

Which agency awarded UG3DA048767?

National Institute on Drug Abuse (National Institutes of Health) awarded UG3DA048767, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award